Pharmacy Report Archives - Page 48 of 150 - Becker's Hospital Review

25 priciest drugs for hospitals | 4 Ozempic updates | New bladder cancer drug approved | Healthcare's imposter problem | Texas system invests in drug-delivery drones

April 24, 2024 BHR Newsletter 1. 25 most expensive hospital drugs Full story 2. Drones to deliver meds, supplies to Memorial Hermann patients Full story 3. ASHP names candidates for board of directors Full story 4. Don't let scheduling become…

How to protect pharmacy residencies: ASHP | Cardinal, OptumRx break up | ISMP: Avoid these abbreviations | Fla. system lays off CEO, staff | Atlantic Health targets polypharmacy

April 23, 2024 BHR Newsletter 1. ISMP updates list of error-prone medical abbreviations Full story 2. Cardinal Health, OptumRx break up Full story 3. ASHP releases toolkit to protect pharmacy residency programs Full story 4. Employee benefit costs are soaring.…

FDA adds warning to 6 CAR-T drugs | Ga. system promotes pharmacy exec | Weight loss drug shortages drag on | CHS receives Mark Cuban co.'s meds | HHS finalizes 340B dispute rule

April 22, 2024 BHR Newsletter 1. FDA adds new warning to CAR-T therapies Full story 2. Emory Healthcare promotes pharmacy leader Full story 3. Mark Cuban's company ships drugs to CHS Full story 4. 2 NewYork-Presbyterian clinics cut wait times…

Mounjaro's label may expand | 15 largest US pharmacies | Pharmacists to demonstrate at Walgreens HQ | 9 potential use cases for GLP-1s | The rise of 'social prescribing'

April 18, 2024 BHR Newsletter 1. Eli Lilly to seek label expansion for Mounjaro, Zepbound Full story 2. The nation's 15 biggest pharmacies Full story 3. Walgreens pharmacists plan Chicago-area demonstrations Full story 4. This often-overlooked strategy saved one critical…

10 of 20 popular drugs in shortage | A 4-letter red flag | Anesthesiologist convicted of drug tampering | Bird flu vaccines underway: HHS | Pfizer to lay off 119

April 17, 2024 BHR Newsletter 1. MD Anderson partners on mRNA cancer vaccines Full story 2. 10 of 20 most popular drugs are in shortage Full story 3. A 4-letter red flag for healthcare leaders Full story 4. Employee benefit costs…

Rite Aid to close more stores | 15 biggest specialty pharmacies | FDA puts syringes on import alert | The 8 a.m. meeting debate | Calif. drugmaker weighs sale | Leqembi's slow rollout

April 16, 2024 BHR Newsletter 1. Top 15 specialty pharmacies by 2023 revenue Full story 2. Rite Aid to shutter additional locations Full story 3. California drugmaker weighs sale Full story 4. Prepare for a DEA inspection and successfully navigate…

10 notes on today's hospital pharmacies | US sues NY drugmaker | 7 prior auth updates | Mark Cuban's 25 steepest drug price cuts | Systems face more than 1 math problem

April 15, 2024 BHR Newsletter 1. The state of hospital pharmacies in 2024: 10 notes Full story 2. Congress probes popular China-based drugmaker Full story 3. US sues Regeneron Pharmaceuticals Full story 4. This often-overlooked strategy saved one critical access…

Drug shortages hit 23-year high | Best pharmacy schools: US News | RSV shot finds success in new age group | 10 systems seeking pharmacy leaders | Wegovy could cut sleep apnea prevalence

April 11, 2024 BHR Newsletter 1. RSV vaccine is safe for young, middle-aged adults: Pfizer Full story 2. CMS pitches inpatient payment rule for 2025: 8 things to know Full story 3. Drug shortages hit 23-year high: ASHP Full story…

Rx delay led to death, cost hospital $42M: Study | PBMs ranked by market share | CVS Health's highest-paid execs | Pros, cons of MA's biosimilar rule | 11 top business schools: US News

April 10, 2024 BHR Newsletter 1. Ozempic predecessor may slow Parkinson's progression, new study shows Full story 2. How pharmacy miscommunication can result in patient death: Case study Full story 3. Top PBMs by 2023 market share Full story 4.…

Pharmacist pay by state | A possible Ozempic baby boom | Kaiser pharmacists get raise | 10 best, worst states for remote work | ALS drug to exit market | Top 150 healthcare workplaces

April 9, 2024 BHR Newsletter 1. A possible Ozempic baby boom Full story 2. Kaiser pharmacists secure mid-contract wage increases Full story 3. Amylyx to pull ALS drug from market after study failure Full story 4. Prepare for a DEA…